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Selective labelling and eradication of antibiotic-
tolerant bacterial populations in Pseudomonas
aeruginosa bioﬁlms
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Michael Givskov1,5, Siu Kwan Sze4, Tim Tolker-Nielsen5 & Liang Yang1,4
Drug resistance and tolerance greatly diminish the therapeutic potential of antibiotics against
pathogens. Antibiotic tolerance by bacterial bioﬁlms often leads to persistent infections, but
its mechanisms are unclear. Here we use a proteomics approach, pulsed stable isotope
labelling with amino acids (pulsed-SILAC), to quantify newly expressed proteins in
colistin-tolerant subpopulations of Pseudomonas aeruginosa bioﬁlms (colistin is a ‘last-resort’
antibiotic against multidrug-resistant Gram-negative pathogens). Migration is essential for
the formation of colistin-tolerant bioﬁlm subpopulations, with colistin-tolerant cells using
type IV pili to migrate onto the top of the colistin-killed bioﬁlm. The colistin-tolerant
cells employ quorum sensing (QS) to initiate the formation of new colistin-tolerant
subpopulations, highlighting multicellular behaviour in antibiotic tolerance development.
The macrolide erythromycin, which has been previously shown to inhibit the motility and
QS of P. aeruginosa, boosts bioﬁlm eradication by colistin. Our work provides insights on
the mechanisms underlying the formation of antibiotic-tolerant populations in bacterial
bioﬁlms and indicates research avenues for designing more efﬁcient treatments against
bioﬁlm-associated infections.
DOI: 10.1038/ncomms10750 OPEN
1 Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, Singapore 637551, Singapore. 2 NUS Graduate
School of Integrative Sciences and Engineering, National University of Singapore, Singapore 117543, Singapore. 3 Interdisciplinary Graduate School, Nanyang
Technological University, Singapore 637551, Singapore. 4 School of Biological Sciences, Division of Structural Biology and Biochemistry, Nanyang
Technological University, Singapore 639798, Singapore. 5 Costerton Bioﬁlm Center, Department of Immunology and Microbiology, University of Copenhagen,
2200 København N, Denmark. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to L.Y.
(email: yangliang@ntu.edu.sg) or S.K.S. (email: sksze@ntu.edu.sg).
NATURE COMMUNICATIONS | 7:10750 |DOI: 10.1038/ncomms10750 |www.nature.com/naturecommunications 1
T
he therapeutic efﬁcacy of antibiotics can be severely
crippled by two major bacterial defence strategies.
‘Resistance’ occurs when bacteria acquire genetic
mutations or mobile genetic elements that enable growth under
conditions of constant antibiotic exposure1, while ‘tolerance’ is
mediated by transient phenotypic variations (based on protein
expression) that enable bacteria to survive exposures to the
highest deliverable doses of antibiotics2,3.
While the current view is that development of tolerance is
intrinsically linked to the bioﬁlm lifestyle, early experiments
conducted on bacteria in the planktonic lifestyle revealed that
tolerance can develop to a number of stresses including
antibiotics4,5. However, in contrast to the planktonic mode of
life, bioﬁlms are sessile, densely populated multicellular
communities embedded in biopolymeric matrix components6.
A major advantage for bacteria that aggregate into bioﬁlms is
that a multitude of matrix components and physiological states
offers additional levels of protection against immune defences
and antibiotics, which cannot be obtained in the planktonic
growth mode7–9. It is widely accepted that pathogenic bacteria
in the bioﬁlm mode signiﬁcantly contribute to the development
of nosocomial infections as they are colonizing hospital settings
and chronic infection sites, where they represent a serious
threat to public health6. Bacterial cells differentiate into several
physiologically distinct subpopulations within a bioﬁlm10.
Antibiotic treatment often eradicates sensitive subpopulations,
but leaves small antibiotic-tolerant subpopulations behind,
resulting in recurring infections after antibiotic treatment
has been stopped10. Antibiotic-tolerant bacterial cells are
variants of wild-type cells that can revert back to the wild type
when antimicrobial treatment has ceased11. Their transient
nature and low abundance make it difﬁcult to investigate their
tolerance-related physiology.
With only a few studies that have investigated planktonic
antibiotic-tolerant cells by pre-isolating them using ﬂow
cytometry12–15, the mechanisms underlying the formation of
antibiotic-tolerant subpopulation in bioﬁlms have remained
elusive. Moreover, these pre-isolation-based strategies are
destructive and not feasible for studying the antibiotic-tolerant
subpopulations in bioﬁlms. This prompted us to develop an
alternative, high-resolution ‘-omics’ approach to simultaneously
characterize the physiologies of sensitive and antibiotic-tolerant
subpopulations in bioﬁlms.
Pseudomonas aeruginosa forms bioﬁlm with extreme tolerance
to antibiotics in nosocomial infections, such as pneumonia and
surgical site infections, prompting the Centers for Disease Control
and Prevention to classify P. aeruginosa under ‘serious’-threat level
(http://www.cdc.gov/drugresistance/threat-report-2013/) and the
Infectious Diseases Society of America to declare it as one of the
six ‘top-priority dangerous, drug-resistant microbes’16. Colistin is a
last-resort polymyxin antibiotic available for treatment of
infections caused by drug-resistant Gram-negative bacteria17.
P. aeruginosa bioﬁlms in ﬂow chambers develop colistin-tolerant
cells rapidly and these cells feature high expression levels of the
pmr operon18.
Here we observe the dynamic development of drug-tolerant
subpopulations in P. aeruginosa bioﬁlms after treatment with
colistin. To obtain knowledge about the physiology of the
colistin-tolerant bioﬁlm cells, we apply pulsed stable isotope
labelling with amino acids (pulsed-SILAC) proteomics method to
selectively quantify the newly expressed proteins that incorporate
and are thus labelled with heavy C13 lysine, to promote
understanding of the colistin-tolerant subpopulation physiology.
The colistin-tolerant populations are able to migrate to the top
of the dead bioﬁlm by employing type IV pili-dependent
motility and initiate formation of new bioﬁlm via quorum
sensing (QS)-regulated group activity. Synergistic treatment by
use of erythromycin, which can inhibit QS and motility with
colistin, is able to boost the elimination of P. aeruginosa bioﬁlms.
Hence, our study provides key insights in developing novel
treatments against bioﬁlm-associated infections, which otherwise
prove hard to eradicate.
Results and Discussion
Development of colistin-tolerant subpopulations in bioﬁlms.
We monitored the development of live and dead subpopulations
of P. aeruginosa bioﬁlms after exposure to colistin in real-time
by using time series confocal image acquisition as well as
enumeration of viable cells with colony forming units
(c.f.u. per ml). Colistin exposure of P. aeruginosa wild-type
bioﬁlms tagged with green ﬂuorescent protein (GFP) led to a
sudden reduction in cell viability according to the propidium
iodide (PI) dead staining (Fig. 1a and Supplementary Movies 1
and 2) and c.f.u. per ml counting (Fig. 1b). However, we
noticed that a few P. aeruginosa cells localized at the substratum
of the bioﬁlms remained alive even after 24 h of colistin
treatment (Fig. 1a), which might result from the heterogeneous
compositions/structures of the exopolymeric matrix
materials19,20. Certain exopolymeric matrix components might
act as physical barriers and reduce the penetration of colistin
into deep part of bioﬁlms21, which allows a few bioﬁlm cells at the
substratum to survive and acquire colistin tolerance.
Interestingly, we observed that colistin-tolerant subpopulations
were able to migrate towards the top of the large microcolonies of
dead P. aeruginosa bioﬁlm cells (Fig. 1a,b and Supplementary
Movies 3 and 4). Tracking of colistin-tolerant cell aggregates close
to the large microcolonies revealed that those aggregates moved
towards the dead microcolonies (Fig. 1c and Supplementary
Movies 3 and 4)—a migration that was unrelated to the ﬂow
direction of the culture medium (from top to bottom of the
image). In contrast, single colistin-tolerant cells far away from the
large microcolonies appeared randomly distributed (Fig. 1c and
Supplementary Movies 3 and 4). These results suggested that
migration of colistin-tolerant cell aggregates towards large
microcolonies of dead bioﬁlm cells was a coordinated process
that might involve speciﬁc signals.
Colistin-tolerant cells obtained from bioﬁlms only showed
transient expression of the pmr operon (Supplementary Fig. 1a)
and lost their colistin tolerance after overnight culturing in
ABTGC medium containing no colistin (Supplementary
Fig. 1b,c), supporting our view that the colistin-tolerant cells
were the result of phenotypic variation and not per se resistant
cells. DNA sequencing of the bioﬁlms with and without colistin
treatment showed that there was no convergent non-synonymous
mutation gained by the three colistin-treated bioﬁlm populations
compared with the control bioﬁlm populations (Supplementary
Data 1). The development of motile colistin-tolerant subpopula-
tions in bioﬁlms has major clinical implications as they can result
in persistent infections.
Using pulsed-SILAC to study colistin-tolerant subpopulations.
To further understand the process that caused the directed motility
and formation of colistin-tolerant bioﬁlm subpopulations, we
further used the pulsed-SILAC quantitative proteomic approach,
with the aim of studying new proteins’ abundance in the
colistin-tolerant subpopulations formed by P. aeruginosa bioﬁlms
after a high-dose colistin treatment (Fig. 2a). We hypothesized that
the actively expressed proteins in the colistin-tolerant sub-
populations provided the survival advantages to the bacteria.
SILAC is a simple and fast but powerful in vivo method,
commonly used for eukaryotes to label proteins for mass
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spectrometry (MS)-based quantitative proteomics22. Although this
method had been used in labelling prokaryotes to compare bioﬁlm
and planktonic cells23,24, pulsed-SILAC had never been employed
to determine new proteins’ abundance in the antibiotic-sensitive
and -tolerant subpopulations coexisting in the same bacterial
bioﬁlm.
A P. aeruginosa mutant that cannot synthesize lysine,
mPAO1DlysA, was employed to form bioﬁlms in medium
supplemented with C12 L-lysine. Although this mPAO1DlysA
mutant could only grow in the presence of L-lysine
(Supplementary Fig. 2), it formed bioﬁlms similar to wild-type
mPAO1 when lysine was added to the culture medium
(Supplementary Fig. 3). Bioﬁlms were treated with high doses
of colistin at 10 mgml 1 (10-fold higher than the minimum
bactericidal concentration) in minimal medium supplemented
with C12 L-lysine for 8 h. After killing the antibiotic-sensitive
population, the remaining surviving antibiotic-tolerant cells
were then treated with fresh medium containing colistin and
C13 L-lysine for 48 h to incorporate C13 L-lysine into the newly
expressed proteins of only live cells (Fig. 2a).
This pulsed-labelling approach allowed for selective tagging of
newly expressed proteins in the antibiotic-tolerant subpopula-
tions, with C13 L-lysine without prior physical isolation. The level
of new protein abundance could be normalized by dividing the
relative abundances of C13 L-lysine-tagged proteins (proteins
expressed after colistin treatment) with the relative abundances of
C12 L-lysine-tagged proteins (proteins expressed before colistin
treatment).
We used Q Exactive MS to analyse the pulsed-SILAC labelled
samples, followed by the MaxQuant and Andromeda
software25,26 to identify 4,250 P. aeruginosa proteins with o1%
false discovery rate (FDR). Only proteins that were signiﬁcantly
and consistently changed/regulated in three biological replicates
(variability o30%) were shortlisted for further analysis
(Supplementary Data 2). Lowly and highly expressed proteins
in the colistin-tolerant subpopulation as compared with the
colistin-sensitive population are functionally grouped in Fig. 2b,c,
respectively, while the complete list of lowly and highly expressed
proteins are listed in Supplementary Data 3 and 4, respectively.
Our initial analysis of the data showed that some of the actively
expressed proteins were subunits of ribosomes (Supplementary
Data 4), supporting the notion that colistin-tolerant cells
are metabolically active27. We also found that the bifunctional
polymyxin-resistance proteins ArnA and PmrA were expressed
at a high level in antibiotic-tolerant cells (Supplementary
Data 2, markers intensity sheet: ArnA (intensity L:H¼ 1.51Eþ
10:4.58Eþ 10); PmrA (intensity L:H¼ 5.26Eþ 09:1.12Eþ 10)).
The arnBCADTEF lipopolysaccharide-modiﬁcation operon had
been shown to be controlled by the upstream pmr operon and
contribute to the tolerance to polymyxin B and colistin in P.
aeruginosa28. Hence, both proteins served as positive controls and
showed that pulsed-SILAC was highly reliable in detecting proteins
important in colistin tolerance. These two markers were
consistently detected with high abundance level in the heavy C13
lysine-labelled proteins in seven out of eight technical replicates of
the three biological replicates except in BR1:R2, where ArnA was
not detected in the light C12 condition, and PmrA was not detected
in both H and L conditions due to technical variation
(Supplementary Data 2, markers intensity sheet). The missing
detection of marker proteins in BR1:R2 might be attributed to
growth variations during bioﬁlm cultivation as bioﬁlm experiments
normally require a long cultivation period (5 days).
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Figure 1 | The migration and formation of colistin-tolerant subpopulations in bioﬁlm. (a) P. aeruginosa PAO1 wild-type bioﬁlms were treated with minimal
medium containing 10mgml 1 colistin followed by real-time CLSM observation from 2 to 32 h of treatment. Scale bars, 50mm. Colistin-tolerant cells in
P. aeruginosa PAO1 bioﬁlms migrated onto the dead bioﬁlm and formed a live colistin-tolerant bioﬁlm. Culture medium ﬂow through on top of the bioﬁlms
from the top of image. Experiments were performed in triplicate, and a representative image for each condition is shown. Live cells appear green, whereas
dead cells appear red or yellow. Videos of the migration and formation of colistin-tolerant bioﬁlm are available in online Supplementary Videos 1 and 2.
(b) C.f.u. per ml of the PAO1 bioﬁlms after 0, 6, 24 and 48 h of colistin treatment. The means and s.d. from three experiments were shown. (c) Movement
trajectories and track displacement of live colistin-tolerant cell aggregates moving onto the dead bioﬁlm. Culture medium ﬂow through on top of the
bioﬁlms from top of image. Scale bars, 10mm.
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Figure 2 | Workﬂow of pulsed-SILAC proteome analysis of antibiotic-tolerant and -sensitive subpopulations. (a) Bioﬁlms were grown in medium
containing C12 L-lysine for 72 h and were then treated with medium containing 10mgml 1 colistin for 6 h to allow the development of colistin-tolerant cells.
Colistin-tolerant subpopulations were then treated with medium containing C13 L-lysine and 10mgml 1 colistin to label the tolerant cells with C13. Cells
were collected, and pulsed-SILAC proteome analysis was conducted to determine the protein abundance in the colistin-tolerant cells in which the new
synthesized proteins are tagged with C13 L-lysine, while the proteome of colistin-susceptible bioﬁlm cells contain the normal C12 L-lysine. Downregulated:
lowly expressed proteins in the colistin-tolerant cells (b); and upregulated: highly expressed proteins in the colistin-tolerant cells (c); proteins in antibiotic-
tolerant cells were classiﬁed into function groups.
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Pili and QS led to colistin tolerance. Interestingly, we found
that antibiotic-tolerant subpopulations also expressed proteins
required for type IV pili assembly, such as PilF (ref. 29, at
high levels (Supplementary Data 4). Hence, we hypothesized
that type IV pili are required for the migration of colistin-tolerant
cell aggregates onto the dead microcolonies. Migration of
colistin-tolerant subpopulations was decreased in bioﬁlms formed
by the type IV pili mutant, DpilA (Fig. 3a,b). Complementation of
DpilA with pDA2, a plasmid containing the pilA gene in a
pUCP18 vector, restored the antibiotic-tolerant phenotype
(Fig. 3a,b).
Furthermore, we found that QS-regulated proteins, including
LasB, chitinase and phenazine/pyocyanin-synthesis (Phz) proteins,
were highly expressed in colistin-tolerant antibiotic-tolerant
subpopulations (Supplementary Data 4). Because QS coordinates
group behaviour in bioﬁlms30, we thus hypothesized that QS
coordinates the development of antibiotic-tolerant microcolonies
within bioﬁlms. The QS null mutant, DlasIDrhlI, developed less
antibiotic-tolerant subpopulations in response to colistin treatment
than the wild type (Fig. 3a,b). Chemical complementation by the
addition of 1mM N-3-(oxododecanoyl)-L-homoserine lactone
(OdDHL) (a QS signalling molecule) to DlasIDrhlI bioﬁlms
allowed DlasIDrhlI to regain the development of colistin-tolerant
subpopulations (Fig. 3a,b). We further showed that bioﬁlms
formed by a QS and type IV pili-defective triple mutant,
DpilADlasRDrhlR, could only develop a negligible amount of
antibiotic-tolerant subpopulations in response to colistin treatment
as compared with the wild type (Fig. 3a,b).
We found that type IV pili-mediated migration preceded
induction of QS activity in the colistin-tolerant subpopulations.
The QS reporter lasB-gfp translational fusion31 was highly
expressed in antibiotic-tolerant subpopulations of wild-type
bioﬁlms but not in the antibiotic-tolerant subpopulations of
DpilA bioﬁlms in response to colistin exposure (Fig. 4a). Colistin-
tolerant bioﬁlms produced more OdDHL, the QS autoinducer,
than wild-type bioﬁlms (Fig. 4b). In response to colistin treatment,
colistin-tolerant wild-type bioﬁlms also secreted more elastase and
pyocyanin than untreated bioﬁlms, which correlates with our
proteomic data that LasB and pyocyanin-synthesis proteins were
highly expressed in colistin-tolerant bioﬁlm cells (Fig. 4c,d).
Given the active expression of virulence factors in the colistin-
tolerant subpopulations, we evaluated the macrophage-killing
capacity of supernatants from wild-type bioﬁlms with and
without colistin treatment by using the mouse RAW264.7 cell
line. After staining the dead macrophages with 20 mM PI, we
observed that the supernatant from colistin-treated bioﬁlms was
more cytotoxic to macrophages than that of control bioﬁlms
(Supplementary Fig. 4). Induction of QS-regulated virulence
factors in colistin-tolerant microcolonies is clinically relevant
because they are detrimental to the host immune system32–36.
It is unclear why the colistin-tolerant cell aggregates migrate to
the top of dead bioﬁlms. Our previous work demonstrated that
the motile subpopulation of the wild-type P. aeruginosa bioﬁlms
migrate towards the non-motile subpopulation to seek iron
source37. We hypothesized that the tolerant cells migrate to
acquire iron. To test this hypothesis, we added the iron chelator
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Figure 3 | The role of pili and QS in the development of antibiotic-tolerant subpopulations in bioﬁlms. (a) Bioﬁlms were cultivated for 72 h using P.
aeruginosa PAO1, DpilA, DpilA/pDA2, DlasIDrhlI, DlasIDrhlIþOdDHL and DpilADlasRDrhlR strains, followed by treatment with medium containing
10mgml 1 colistin. No migration of tolerant subpopulation was observed for DpilA mutant bioﬁlms, and the majority of the cells in DpilA bioﬁlms were
killed by colistin. Complementation of DpilA with pDA2 restored the antibiotic-tolerant subpopuation development after colistin treatment. The QS-
defective DlasIDrhlI mutant bioﬁlms could only develop small amount of antibiotic-tolerant subpopulation after colistin treatment. Addition of OdDHL
partially restored the development of antibiotic-tolerant subpopulation after colistin treatment. The pili and QS-defective DpilADlasRDrhlR mutant bioﬁlms
were unable to develop antibiotic-tolerant subpopulation after colistin treatment. The central images show horizontal optical sections, whereas the ﬂanking
images show vertical optical sections. Live cells appear green and dead cells appear red. Scale bars, 50mm. (b) Live/dead ratios of 72-h bioﬁlms formed by
P. aeruginosa PAO1, DpilA, DpilA/pDA2, DlasIDrhlI, DlasIDrhlIþOdDHL and DpilADlasRDrhlR strains after colistin treatment. The mean and s.d. from three
experiments is shown. *Po0.01, Student’s t-test.
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2,2-dipyridyl (DIPY)38 together with colistin to treat
P. aeruginosa wild-type bioﬁlms. We found that DIPY was able
to interfere with the development of colistin-tolerant
subpopulations associated with the dead microcolonies
(Supplementary Fig. 5).
Hence, in addition to mechanisms directly involved in
antibiotic tolerance, we showed that multicellular behaviours
such as migration and cell–cell signalling (QS) are important in
the recovery of pathogenic bioﬁlms that can survive the
otherwise lethal antibiotic treatments. Since clinical departments
only test for resistance (growth versus no growth on
medium supplemented with antibiotics) before the
commencement of antibiotic treatments of the patient, the
development of antibiotic-tolerant subpopulations in response
to exposures can be considered a concealed mechanism of
antibiotic recalcitrance.
Chemical Approach to combat colistin-tolerant subpopulations.
Given that both type IV pili-mediated migration and QS are
required for establishing antibiotic-tolerant subpopulations
in developing P. aeruginosa bioﬁlm, we employed a chemical
biology approach to disable these activities. Macrolides,
which can inhibit type IV pili assembly and QS in
P. aeruginosa39, were used in combination with colistin to treat
P. aeruginosa bioﬁlms.
Treatment with erythromycin had a mild killing effect on
bioﬁlm cells and planktonic cells (Fig. 5a–c, respectively),
implying that erythromycin was unable to kill the bioﬁlms.
However, combination treatments with erythromycin and colistin
lead to complete eradication and repression of the development
of antibiotic-tolerant subpopulations (Fig. 5a,b). Supporting that
our combination treatment was speciﬁc to the colistin-tolerant
cells present in the bioﬁlm mode of life, we did not observe the
synergistic effect of colistin and erythromycin against planktonic
P. aeruginosa at concentrations equivalent to that of the bioﬁlm
treatment (Fig. 5c).
To verify the functional eradication of antibiotic-tolerant cells by
both antibiotics in vivo, we used a murine model for implant-
associated infection40. As opportunistic infections on the host
could occur when bioﬁlm is formed on implants such as catheters
and heart valves, treatments that prevent the rise of antimicrobial-
tolerant or -resistant populations are essential41,42. Implants coated
with P. aeruginosa bioﬁlms were surgically inserted into the
peritoneum of mice. The mice were treated locally with antibiotics
to emulate the treatment given to patients with infections from
implants. The concentration of antibiotics (1mgkg 1 colistin and
10mgkg 1 erythromycin) used for each mouse was well below
the median lethal dose of each antibiotic (86mgkg 1 colistin and
280mgkg 1 erythromycin), ensuring the non-lethal treatment of
P. aeruginosa bioﬁlm in the mouse.
The c.f.u. per ml count of P. aeruginosa from the implant and
spleen after 24 h incubation in the mouse revealed that
administration of colistin or erythromycin alone did not eradicate
the infection. However, synergistic treatments with colistin and
erythromycin eradicated the bioﬁlm to the limit of detection by
c.f.u. per ml (Fig. 5d). Since we were unable to detect live bacterial
cells in the spleen samples, we concluded that the spread of
infection was also halted (Fig. 5e). Hence, supplementing
conventional antibiotic treatment with a tolerance-interfering
compound appears to be a promising therapy for eradicating
bioﬁlm-associated infections.
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Figure 4 | QS-related products are upregulated in antibiotic-tolerant subpopulations in P. aeruginosa bioﬁlms. (a) The 72-h bioﬁlms formed by the P.
aeruginosa PAO1 and DpilA containing the lasB-gfp translational fusion were treated with medium containing 10mgml 1 colistin for 24 h followed by CLSM
observation. The lasB-gfp translational fusion was induced to high levels in PAO1 colistin-tolerant cells but was not observed in DpilA bioﬁlms. Experiments
were performed in triplicate, and a representative image for each condition is shown. Live cells appear green, whereas dead cells appear yellow or red. The
central images show horizontal optical sections, whereas the ﬂanking images show vertical optical sections. Scale bars, 50 mm. (b) Antibiotic-tolerant cells
from PAO1 bioﬁlms secreted more OdDHL than untreated bioﬁlm cells. (c) Antibiotic-tolerant cells from PAO1 bioﬁlms produced more elastase than
untreated bioﬁlm cells. (d) Antibiotic-tolerant cells from PAO1 bioﬁlms produced more pyocyanin than untreated bioﬁlm cells. The mean and s.d. from
three experiments is shown. *Po0.01, Student’s t-test.
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The association between type IV pili and the colistin-tolerant
subpopulations in developing P. aeruginosa bioﬁlm has
been presented previously18, whereas the position in a
nutrient-rich microenvironment seems to be important for the
development of colistin-tolerant subpopulations in more
mature P. aeruginosa bioﬁlms27. We here tracked the formation
of antibiotic-tolerant subpopulations in developing P. aeruginosa
bioﬁlms and used pulsed-SILAC to selectively label
their proteome to determine new protein abundance in the
antibiotic-tolerant subpopulations, which led to the identiﬁcation
of multiple genes/proteins essential for the development of
antibiotic-tolerant bioﬁlm.
We propose the following model for the development of
colistin-tolerant subpopulations in developing P. aeruginosa
bioﬁlm, which links it to the ‘phoenix effect’ (Fig. 6): (a) the
majority of the bioﬁlm is killed by colistin treatment; (b)
surviving antibiotic-tolerant cell aggregates overexpress type IV
pili for targeted migration to the top of the dead bioﬁlm;
(c) and produce QS-regulated factors for promoting the
formation of new antibiotic-tolerant microcolonies. The
microcolony size in our in vitro P. aeruginosa bioﬁlms is around
50 mm, which is within the range of microcolony sizes identiﬁed
from in vivo43,44 and ex vivo45,46 P. aeruginosa bioﬁlms.
This suggested that colistin might have similar effects on
in vivo P. aeruginosa bioﬁlms as those observed on our in vitro
P. aeruginosa bioﬁlms.
Furthermore, our study showed that targeting mechanisms
important to antibiotic-tolerant cells greatly improved
conventional bioﬁlm treatment strategies. It highlighted the
importance of developing QS and motility inhibitors that can be
given to chronically infected patients, with the aim of constituting
functional anti-bioﬁlm chemotherapies. This strategy might
also be applied to other complex differentiated communities,
such as cancer, as a recent study revealed the presence of motile
drug-tolerant cells in chemotherapy-treated cancer cell
populations47.
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Figure 5 | Targeting type IV pili and QS simultaneously leads to eradication of antibiotic-tolerant cells. (a) Colistin-tolerant cells formed in PAO1 ﬂow cell
bioﬁlms after colistin and erythromycin single treatment and combined treatment. Colistin-tolerant cells were unable to form in PAO1 bioﬁlms after combined
erythromycinþ colistin treatment. Experiments were performed in triplicate. Live cells appear green and dead cells appear red. Scale bars, 50mm.
(b) Live/dead ratios were calculated based on CLSM images. The mean and s.d. from ﬁve experiments is shown for in vivo bioﬁlms. *Po0.01, One-way
ANOVA. (c) C.f.u. per ml of PAO1 planktonic cultures treated with colistin, erythromycin and colistinþ erythromycin. The mean and s.d. from three
experiments is shown. C.f.u. per ml of in vivo PAO1 bioﬁlms obtained from implant (d) and cells from the spleen (e), with and without antibiotic treatment.
Dotted horizontal lines represent limit of detection. The mean and s.d. from ﬁve experiments is shown for in vivo bioﬁlms. *Po0.01, Student’s t-test.
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Methods
Bacterial strains and growth conditions. The bacterial strains and plasmids used
in this study are listed in Supplementary Table 1. P. aeruginosa strains were grown
at 37 C in ABT minimal medium48 supplemented with 5 g l–1 glucose (ABTG)
or 2 g l 1 glucose and 2 g l–1 casamino acids (ABTGC). For marker selection in
P. aeruginosa, 30mgml 1 gentamicin and 200 mgml 1 carbenicillin were used
as appropriate.
Cultivation of bioﬁlms in ﬂow chambers. MiniTn7-gfp-tagged P. aeruginosa
bioﬁlms were cultivated in ABTG medium at 37 C using 40mm 4mm 1mm
three-channel ﬂow chambers. Flow chambers were assembled as described pre-
viously, consisting of a ﬂow cell that acted as a chamber for the growth of bio-
ﬁlms49. The ﬂow cell was supplied with a ﬂow of medium and oxygen, while waste
medium was removed into a waste ﬂask, by using a peristaltic pump. Each ﬂow
channel was inoculated with 300ml of a 1:1,000 dilution of an overnight culture
using a syringe and was incubated without ﬂow for 1 h. Medium ﬂow was started
and maintained at a velocity of 0.2mm s 1 by the A Cole-Palmer peristaltic pump.
After 72 h of growth, PAO1 bioﬁlms were treated with 10 mgml 1 colistin. After
48 h of treatment, 300ml of 20 mM PI was injected into each ﬂow channel to stain
dead cells in the bioﬁlm. Experiments were performed in triplicate, and results are
shown as the mean±s.d.
Reversion of antibiotic-tolerant phenotype in bioﬁlms. MiniTn7-gfp-tagged and
pmr-gfp-tagged P. aeruginosa bioﬁlms were cultivated and treated with colistin as
described above. Colistin-containing ABTG medium was switched to antibiotic-free
ABTG to allow the reversion of antibiotic-tolerant phenotype back to normal bioﬁlm
for 48 h. To examine whether the antibiotic-tolerant phenotype can be re-induced,
the bioﬁlms were challenged with 10mgml 1 colistin for the second cycle. A volume
of 300ml of 20mM PI was injected into each ﬂow channel to stain dead cells in the
bioﬁlm. Bioﬁlms were observed at 0 and 4 h after the second challenge of colistin.
Reversion of antibiotic-tolerant cells in planktonic cultures. PAO1 and PAO1/
pmr-gfp bioﬁlm containing the live colistin-tolerant subpopulations and dead
colistin-sensitive subpopulations were obtained from the ﬂow chamber bioﬁlm by
ﬂushing out the entire bioﬁlm with 5ml of 0.9% NaCl. The bioﬁlm was homogenized
by vortexing for 30 s and the cells were washed twice with 1ml 0.9% NaCl. The
antibiotic-tolerant cells were grown in 2ml ABTGC to revert to normal phenotype
and 2ml ABTGC with 10mgml 1 colistin to maintain the colistin-tolerance phe-
notype, at 37 C, 200 r.p.m. for 16 h. The cells were then washed twice in 2ml 0.9%
NaCl. PAO1 cells were serially diluted, plated on Luria–Bertani (LB) agar and
incubated at 37 C overnight. C.f.u. per ml was calculated by multiplying the average
number of colonies by the dilution factor and dividing by the volume. For PAO1/
pmr-gfp cells, ﬂuorescence from pmr-gfp expression (expressed in relative ﬂuores-
cence units, r.f.u.) was measured for each well using a microplate reader (Tecan
Inﬁnite 2000) and was normalized to the OD600 of each well. Experiments were
performed with three replicates, and the results are shown as the mean±s.d.
Viable colony counts of bioﬁlms with colistin treatment. PAO1 bioﬁlms were
cultivated as described above. After 72 h of growth, PAO1 bioﬁlms were treated
with 10 mgml 1 colistin. Bioﬁlms were collected from ﬂow chamber by mechanical
disruption with syringes at 0, 6, 24 and 48 h of colistin treatment. The bioﬁlms were
resuspended in 0.9% NaCl and further homogenized by vortexing. PAO1 cells were
serially diluted, plated on LB agar and incubated at 37 C overnight. C.f.u. per ml
was calculated by multiplying the average number of colonies by the dilution factor
and dividing by the volume. Experiments were performed with three replicates, and
the results are shown as the mean±s.d.
Microscopy and image acquisition of bioﬁlms. All microscopy images were
captured and acquired using an LSM confocal laser scanning microscope (CLSM;
Carl Zeiss, Germany). The  20 objective was used to monitor GFP and PI
ﬂuorescence. IMARIS software (Bitplane AG, Zurich, Switzerland) was used to
process the images. Experiments were performed in triplicate, and representative
images are shown.
Video of antibiotic-tolerant cell migration in bioﬁlms. MiniTn7-gfp-tagged
PAO1 bioﬁlms were treated with 10 mgml 1 colistin and 4 mgml 1 PI. From 24 to
32 h of colistin treatment, videos were captured and acquire using a CLSM with a
 40 objective lens. GFP and PI ﬂuorescence were observed. IMARIS software
(Bitplane AG, Zurich, Switzerland) was used to process the videos. Experiments
were performed in triplicate, and representative videos are shown.
Tracking antibiotic-tolerant cells migration in bioﬁlms. After acquiring videos
as described in previous section, IMARIS software (Bitplane AG) was used to
process the particle tracking of antibiotic-tolerant cells migrating, according to the
manufacturer’s instructions.
DNA sequencing analysis. Genomic DNA of the P. aeruginosa bioﬁlms with and
without 48 h colistin treatment was puriﬁed using QIAamp DNAMini Kit (Qiagen,
Germany) and sequenced on an Illumina MiSeq V3 platform generating 300 bp
long paired-end reads. The experiment was performed in three biological replicates:
three colistin-treated bioﬁlms and three control bioﬁlms. The average insert sizes
are 490–544 nucleotides and the average genomic coverage depths are 63–167
folds. Nucleotide differences were generated from the CLC Genomics Workbench
8.0 (CLC Bio, Aarhus, Denmark), and all of the used parameters were listed in
Supplementary Methods. Brieﬂy, adapters and low-quality reads were trimmed off.
Paired-end reads in FASTQ format of colistin-treated and control bioﬁlm genomes
were ﬁrst mapped against the P. aeruginosa PAO1 genome (NC_002516). Variants
were detected using the low-frequency variant detection method with the required
signiﬁcance of 1%. Convergent non-synonymous variants of colistin-treated bio-
ﬁlm genomes compared with the P. aeruginosa PAO1 reference genome were
obtained with the following criterions: (i) Parallel variants were found in the same
gene in all of the three colistin-treated bioﬁlm samples; and (ii) no variant was
found in the same gene in any of the control bioﬁlm samples.
Pulsed-SILAC. Three independent biological replicates (BR1, BR2 and BR3) were
performed. Bioﬁlms treated with colistin were grown and prepared for pulsed-
SILAC analysis22. PAO1 DlysA bioﬁlms were cultivated in 25 cm 5mm Ø ﬂow
tubes as described previously49, using ABTG medium, 500 mM C12 L-lysine and
192mg l 1 Amino acid Drop-out Mix Minus Lysine without Yeast Nitrogen Base
(United States Biological, MA) at 37 C. Flow channels were inoculated with 1ml of
a 1:1,000 dilution of an overnight culture using a syringe and were incubated
without ﬂow for 1 h. A Cole–Palmer peristaltic pump was used to supply medium
at a velocity of 0.2mm s 1, which corresponds to a laminar ﬂow with a Reynolds
number of 0.02. After culturing for 72 h, bioﬁlms were treated with 10 mgml 1
colistin for 6 h to kill the antibiotic-sensitive cells in bioﬁlms. Bioﬁlms were then
treated with fresh ABTG supplemented with 500 mM C13 L-lysine and 192mg l 1
Amino acid Drop-out Mix minus Lysine without Yeast Nitrogen Base for 48 h to
tag new synthesized proteins in live antibiotic-tolerant cells with C13 L-lysine.
Bioﬁlms were washed with PBS and sonicated by probe sonicator (5 s on, 5 s off for
5min in ice slurry, amplitude 30%) for cell lysis.
Protein samples were separated on a SDS–PAGE gel. Protein bands were washed
with ddH2O mixed with 50% acetonitrile (ACN)/50% 25mM NH4HCO3 via
vigorous vortexing for 30min, and dehydrated with 100% ACN until the gel particles
became white. They were then reduced with 10mM dithiothreitol at 56 C for 1 h
and alkylated with 55mM iodoacetamide (IAA) for 45min in the dark. The proteins
Live cells
Tolerant cells
Dead cells
Development of tolerant cells
Virulence factor
Pretreatment Induction of QS and virulence
a b c
Figure 6 | Model of antibiotic-tolerant cell formation in P. aeruginosa bioﬁlms. (a) Antibiotics such as colistin treatment kill most of the cells in the
bioﬁlms, but leave a few antibiotic-tolerant cells at the bottom of the bioﬁlm. (b) Antibiotic-tolerant cells expand in numbers and migrate to the top of the
bioﬁlm using pilus-mediated motility. (c) Assemblies of antibiotic-tolerant cells induce QS that leads to the production of QS-related virulence factors, such
as elastase and pyocyanin. A new antibiotic-tolerant bioﬁlm is formed.
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were then washed with 25mM NH4HCO3 and 50% ACN/50% 25mM NH4HCO3.
Gel particles were then dehydrated with 100% ACN and dried under vacuum.
Trypsin (V5111, Promega, Madison, WI) was added to the gel particles at a ratio of
1:30, and allowed to be completely adsorbed by the gel particles. A unit of 25mM
NH4HCO3 was then added to completely cover the particles for incubation at 37 C
overnight. Peptides were extracted from the gel particles by two 20-min sonications
in the presence of 50% ACN containing 0.1% Triﬂuoroacetic acid (TFA). Extracts
were combined, vacuum-dried and resuspended in 0.1% FA for liquid
chromatography (LC)–MS/MS analysis.
Peptides were separated and analysed on a Dionex Ultimate 3000 RSLCnano
system coupled to a Q Exactive (Thermo Fisher, MA) as previously described50.
Approximately 1mg of peptide from each pooled fraction was injected into an
Acclaim peptide trap column (Thermo Fisher, MA, USA) via the Dionex RSLCnano
auto-sampler. Peptides were separated in a Dionex EASY-Spray 75mm 10 cm
column packed with PepMap C18 3mm, 100Å (Thermo-Scientiﬁc, MA, USA) at
room temperature. The ﬂow rate was 300 nlmin 1. Mobile phase A (0.1% formic
acid in 5% ACN) and mobile phase B (0.1% formic acid in 90% ACN) were used to
establish a 60-min gradient. Peptides were then analysed on Q Exactive with an
EASY nanospray source (Thermo Fisher, MA) at an electrospray potential of 1.5 kV.
A full MS scan (350–1,600m/z range) was acquired at a resolution of 70,000 at m/z
200 and a maximum ion accumulation time of 100ms. Dynamic exclusion was set as
15 s. The resolution of the higher energy collisional dissociation (HCD) spectra was
set to 17,500 at m/z 200. The automatic gain control (AGC) settings of the full MS
scan and the MS2 scan were 3E6 and 2E5, respectively. The 10 most intense ions
above the 2,000 count threshold were selected for fragmentation in HCD, with a
maximum ion accumulation time of 100ms. An isolation width of 2 was used for
MS2. Single and unassigned charged ions were excluded from MS/MS. For HCD, the
normalized collision energy was set to 28%. The underﬁll ratio was deﬁned as 0.2%.
Two injections have been performed for the ﬁrst biological replicates and three
injections have been performed for the second and third biological replicates,
respectively, to evaluate the technical reproducibility of the instrument and workﬂow.
Raw data ﬁles of the eight technical replicates were processed and searched as eight
experiments using MaxQuant (v1.5.2.8) (refs 25,26) and the Genebank P. aeruginosa
protein database (downloaded on 21 May 2015, 55,063 sequences, 17,906,244
residues) together with the common contaminant proteins. Standard search type
with 2 multiplicity, 3 maximum labelled AAs and heavy labelled Lys6 were used for
the pulsed-SILAC quantitation. The database search was performed using the
Andromeda search engine bundled with MaxQuant using the MaxQuant default
parameters for Q Exactive Orbitrap mass spectrometer. The ﬁrst and main searches
peptide mass tolerance for were 20 and 4.5 parts per million (p.p.m.) respectively,
while the MS/MS match tolerance was 20 p.p.m. with FTMS de-isotoping enabled.
The absence of two trypsin cleavage sites per protein was allowed. Carbamido-
methylation (C) was set as a ﬁxed modiﬁcation. Oxidation (M) and deamidation
(NQ) were set as variable modiﬁcations. The search was performed in the Revert
decoy mode with PSM FDR, protein FDR and site decoy fraction set to 0.01.
A total of 4,382 proteins including 4,250 P. aeruginosa proteins were identiﬁed by
Andromeda in MaxQuant with FDR o1% (Supplementary Data 2). The scatter
plots of inter-technical replicates of each biological replicate were used to evaluate
the technical reproducibility of the results (Supplementary Data 2). The technical
reproducibility is good and follows the order of BR2(R2¼B0.95)4BR3(R2¼
B0.9)4BR1(R2¼ 0.86). To evaluate the repeatability of the biological replicates, all
LC–MS/MS raw data ﬁles of BR1, BR2 or BR3 were grouped and searched,
respectively, using MaxQuant to obtain the pulsed-SILAC protein abundance levels
in the three biological replicates. The scatter plots of inter-biological replicates were
all included in Supplementary Data 2.
Relative quantiﬁcation of OdDHL. Efﬂuents from ﬂow chambers were collected,
ﬁltered through 0.2-mm ﬁlters and the ﬁltrates were collected. Overnight cultures of
the reporter strain DlasIDrhlI/lasB-gfp (ref. 51) were adjusted to OD600¼ 0.15 using
ABTGC medium. A volume of 100ml of ﬁltrate was added to 100 ml of DlasIDrhlI/
lasB-gfp in a 96-well plate (Nunc, Denmark). Because DlasIDrhlI cannot produce
its own OdDHL, lasB-gfp is induced by the addition of ﬁltrates containing OdDHL.
Fluorescence from lasB-gfp expression (expressed in r.f.u.) was measured for each
well using a microplate reader (Tecan Inﬁnite 2000) and was normalized to the
OD600 of each well. Experiments were performed in triplicate, and results are
shown as the mean±s.d.
Elastase assay. Efﬂuents from ﬂow chambers were collected, centrifuged to
remove bacterial cells and ﬁltered through 0.2-mm ﬁlters. An Elastase Assay Kit
(EnzChek) was used according to the manufacturer’s instructions. ABTG medium
was used as the negative control and elastase was used as the positive control. The
ﬂuorescence from each reaction (expressed in r.f.u.) was measured using a
microplate reader (Tecan Inﬁnite 2000) and was normalized to the OD600 for each
well of the 96-well microplate. Experiments were performed in triplicate, and
results are shown as the mean±s.d.
Pyocyanin assay. Relative pyocyanin concentrations were quantiﬁed as described
previously52. Efﬂuents from ﬂow chambers were collected, centrifuged to remove
bacterial cells and ﬁltered through 0.2-mm ﬁlters. ABTG medium was used as the
negative control. A volume of 10ml of ﬁltrate was mixed with 1ml of chloroform
by vortexing. The lower chloroform phase was transferred to a new tube containing
200 ml of 0.2M hydrochloric acid and vortexed. The top phase was then carefully
transferred to a 96-well plate to measure OD520 using a microplate reader (Tecan
Inﬁnite 2000). Experiments were performed in triplicate, and the results are shown
as the mean±s.d.
Cytotoxicity assay for macrophages. In all, 5 105 RAW264.7 (ATCC TIB-71)
murine macrophages were grown in 24-well culture plate as previously described38.
The efﬂuent from the ﬂow chamber bioﬁlms with or without colistin treatment
were collected and ﬁltered through a 0.2-mm ﬁlter to remove bacterial cells. ABTG
media was used as negative control, while ABTG mediaþ 10mgml 1 colistin was
used to show that colistin had no side effects on macrophages. The resultant
supernatant was mixed at equal volumes with fresh DMEM and added to the
macrophages. Macrophages were incubated for 4 h in 37 C, 5% CO2. The
cytotoxicity of the supernatants on macrophages was determined by adding 20 mM
PI to monitor cell integrity. Macrophages stained red by PI under epiﬂuorescent
microscopy ( 20 objective) were counted as dead, leaving the live ones unstained.
Cells from ﬁve images of each samples were enumerated and the ratio of dead cells
to live cells was calculated. Experiments were performed in triplicate, and the
results are shown as the mean±s.d.
Eradication of bioﬁlms with colistin and DIPY iron chelator. Fluorescent-tagged
P. aeruginosa bioﬁlms were cultivated as described above. After 72 h of growth,
PAO1 bioﬁlms were treated with 10mgml 1 colistin or 100mgml 1 DIPY plus
10mgml 1 colistin. After 48 h of treatment, 300ml of 20mM PI was injected into
each ﬂow channel to stain dead cells in the bioﬁlm. Bioﬁlm were observed under the
CLSM as described above. As pyoverdine is a ﬂuorescent metabolite53, its presence
and localization in the bioﬁlm was observed by CLSM with Ex 358 nm/Em 461 nm.
Experiments were performed in triplicate, and results are shown as the mean±s.d.
Eradication of bioﬁlms by colistin and erythromycin. Fluorescent-tagged P.
aeruginosa bioﬁlms were cultivated as described above. After 72 h of growth, PAO1
bioﬁlms were treated with 10 mgml 1 colistin or 100 mgml 1 erythromycin plus
10 mgml 1 colistin. After 48 h of treatment, 300 ml of 20mM PI was injected into
each ﬂow channel to stain dead cells in the bioﬁlm. Bioﬁlm were observed under
the CLSM as described above. Experiments were performed in triplicate, and
results are shown as the mean±s.d.
Time-dependent killing of planktonic PAO1 with erythromycin and colistin.
The minimal inhibitory concentration (MIC) of erythromycin is 2,000 mgml 1,
while the MIC for colistin is 1 mgml 1 in PAO1 strains. Planktonic P. aeruginosa
strains were grown at 37 C in ABTGC with 100 mgml 1 of erythromycin,
10 mgml 1 of colistin and 100mgml 1 of erythromycinþ 10 mgml 1 of colistin.
Cells were collected at 0, 1 and 3 h. PAO1 cells were serially diluted, plated on LB
agar and incubated at 37 C overnight. C.f.u. per ml was calculated by multiplying
the average number of colonies by the dilution factor and dividing by the volume.
Mouse implant infection model. The animals used in this study were 7-week-old
female BALB/c mice (Taconic M&B A/S). The animal experiments were performed
in accordance to the NACLAR Guidelines and Animal and Birds (Care and Use of
Animals for Scientiﬁc Purposes) Rules by Agri-Food & Authority of Singapore
(AVA), with authorization and approval by the Institutional Care and Use Com-
mittee (IACUC) and Nanyang Technological University, under the permit number
A-0191 AZ. PAO1 bioﬁlms were grown on cylindrical implants (3mm 5mm Ø)
in 0.9% NaCl at 37 C with shaking at 110 r.p.m. for 20 h, as described pre-
viously40,54. The bioﬁlm-coated implants were washed three times with 0.9% NaCl
and transplanted into the peritoneum of the mice after they were anesthetized with
100mg kg 1 ketamine and 10mg kg 1 xylene. Antibiotics were injected at the site
of implantation. No antibiotics, 1mg kg 1 colistin, 10mg kg 1 erythromycin, or
1mg kg 1 colistin and 10mg kg 1 erythromycin were used on groups of ﬁve
mice. Mice were killed after 24 h of treatment. Implants were collected, sonicated in
0.9% NaCl in an ice water bath using an Elmasonic P120H (Elma, Germany;
power¼ 50% and frequency¼ 37 KHz) for 10min and vortexed three times for 10 s
to disrupt the bioﬁlms. Spleens were also collected and completely homogenized
using the Bio-Gen PRO200 Homogenizer (Pro Scientiﬁc, US) at maximum power
on ice. Samples were serially diluted, plated on LB agar and incubated at 37 C
overnight. C.f.u. per ml was calculated by multiplying the average number of
colonies by the dilution factor and multiplying by the volume. Experiments were
performed with ﬁve replicates, and the results are shown as the mean±s.d.
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